Trana Discovery Develops Assay to Find New Treatments for Staph Infections

Advancement of assay made possible through a $250,000 loan awarded by the North Carolina Biotechnology Center…

CARY, NC (October 8, 2008) – Trana Discovery, Inc., a drug discovery technology company, today announced plans for the development of a new High-Throughput Screening (HTS) assay ...

Trana Discovery and Southern Research Institute Prove Assay’s Ability to Identify Compounds That Inhibit HIV Replication

Unique HTS assay capable of selecting compounds that work by mechanism other than inhibition of reverse transcriptase

CARY, NC and BIRMINGHAM, Ala. (Jan 15, 2008) – Trana Discovery, a drug discovery technology company, today announced that their recently-developed HIV high-throughput screening ...

Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals

Collaboration validates unique HIV assay system that identifies potential tRNA inhibitors

CARY, NC and BIRMINGHAM, Ala. (Sept. 17, 2007) – Trana Discovery, a drug discovery company, today announced the development of a high throughput screening (HTS) assay ...

Trana Discovery and Southern Research Institute Collaborate to Discover New Classes of Drugs for the Treatment of HIV

Unique assay system to identify anti-infectives that inhibit tRNA

CARY, NC and BIRMINGHAM, Ala. (Dec. 13, 2006) – Trana Discovery, a drug discovery company, and Southern Research Institute, a contract research organization conducting basic and applied preclinical drug research, ...

APRIL 2006:

Company will commercialize North Carolina State University drug discovery technology

CARY, NC – A veteran team of five former Glaxo executives has joined Trana Discovery, Inc. (formerly known as Neos Discovery) to commercialize technology that identifies drug compounds that interrupt the lifecycle of pathogens through a novel mechanism of action – the inhibition of transfer ribonucleic acid (tRNA).  The use ...